U.S. markets open in 8 hours 15 minutes
  • S&P Futures

    4,534.75
    +26.25 (+0.58%)
     
  • Dow Futures

    34,216.00
    +214.00 (+0.63%)
     
  • Nasdaq Futures

    15,944.75
    +75.00 (+0.47%)
     
  • Russell 2000 Futures

    2,165.70
    +19.40 (+0.90%)
     
  • Crude Oil

    66.39
    +0.82 (+1.25%)
     
  • Gold

    1,777.40
    -6.90 (-0.39%)
     
  • Silver

    22.36
    +0.03 (+0.12%)
     
  • EUR/USD

    1.1326
    +0.0004 (+0.03%)
     
  • 10-Yr Bond

    1.4340
    0.0000 (0.00%)
     
  • Vix

    31.12
    +3.93 (+14.45%)
     
  • GBP/USD

    1.3288
    +0.0011 (+0.08%)
     
  • USD/JPY

    113.0560
    +0.2760 (+0.24%)
     
  • BTC-USD

    56,598.70
    -385.41 (-0.68%)
     
  • CMC Crypto 200

    1,436.58
    -32.50 (-2.21%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,833.14
    -102.48 (-0.37%)
     

Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?

·4 min read
Novavax Faces 1 Major Risk Right Now. Should You Buy the Stock Anyway?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Novavax (NASDAQ: NVAX) started the coronavirus vaccine race as a favorite. Manufacturing issues have delayed Novavax's submission for emergency authorization in the U.S. and other countries. A news report suggested Novavax's delays may not be over.